Flow cytometric assessment of agonist-induced P-selectin expression as a measure of platelet quality in stored platelet concentrates

Transfusion

Volumn 53, Issue 8, 2013, Pages 1780-1787

  Middelburg, Rutger A ^b   Roest, Mark ^a   Ham, Jannemieke ^a   Coccoris, Miriam ^a   Zwaginga, Jaap Jan ^a   Van Der Meer, Pieter F ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; PADGEM PROTEIN; RIBOFLAVIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THROMBOCYTE CONCENTRATE;

ARTICLE; FLOW CYTOMETRY; IN VITRO STUDY; LIGHT SCATTERING; PROTEIN EXPRESSION; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY;

ANNEXIN A5; BIOLOGICAL MARKERS; BLOOD PLATELETS; BLOOD PRESERVATION; BLOOD SAFETY; FLOW CYTOMETRY; HUMANS; LINEAR MODELS; P-SELECTIN;

EID: 84882407357     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12001     Document Type: Article

References (16)

1. Blajchman MA, Slichter SJ, Heddle NM, Murphy MF,. New strategies for the optimal use of platelet transfusions. Hematology Am Soc Hematol Educ Program 2008; 198-204.
2. Slichter SJ,. Relationship between platelet count and bleeding risk in thrombocytopenic patients. Transfus Med Rev 2004; 18: 153-167.
3. Buhrkuhl DC,. An update on platelet transfusion in hematooncology supportive care. Transfusion 2010; 50: 2266-2276.
4. Panzer S, Jilma P,. Methods for testing platelet function for transfusion medicine. Vox Sang 2011; 101: 1-9.
5. Maurer-Spurej E, Labrie A, Pittendreigh C, Chipperfield K, Smith C, Heddle N, Liu Y, Yi QL, Barnett M,. Platelet quality measured with dynamic light scattering correlates with transfusion outcome in hematologic malignancies. Transfusion 2009; 49: 2276-2284.
6. van der Meer PF, Kerkhoffs JL, Curvers J, Scharenberg J, de, Korte D, Brand A, de, Wildt-Eggen J,. In vitro comparison of platelet storage in plasma and in four platelet additive solutions, and the effect of pathogen reduction: a proposal for an in vitro rating system. Vox Sang 2010; 98: 517-524.
7. Roeloffzen WW, Kluin-Nelemans HC, Veeger NJ, Bosman L, de, Wolf JT,. Transfused stored platelets have the same haemostatic function as circulating native platelets. Vox Sang 2010; 99: 123-130.
8. van Bladel ER, Roest M, de, Groot PG, Schutgens RE,. Up-regulation of platelet activation in hemophilia A. Haematologica 2011; 96: 888-895.
9. Snoep JD, Eikenboom JC, Zwaginga JJ, Roest M, Patrono C, Rocca G, Petrucci G, Rosendaal FR, van der, Bom JG,. Platelet reactivity and recurrent cardiovascular events in patients with stable cardiovascular disease using aspirin: a head-to-head comparison of different tests. [cited 2012 Nov 9]. Available from: URL: https://openaccess.leidenuniv.nl/bitstream/handle/1887/ 16498/ch-06.pdf?sequence=7
10. Cookson P, Thomas S, Marschner S, Goodrich R, Cardigan R,. In vitro quality of single-donor platelets treated with riboflavin and ultraviolet light and stored in platelet storage medium for up to 8 days. Transfusion 2011; 52: 983-994.
11. Galan AM, Lozano M, Molina P, Navalon F, Marschner S, Goodrich R, Escolar G,. Impact of pathogen reduction technology and storage in platelet additive solutions on platelet function. Transfusion 2011; 51: 808-815.
12. Reikvam H, Marschner S, Apelseth TO, Goodrich R, Hervig T,. The Mirasol Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution. Blood Transfus 2010; 8: 186-192.
13. Mirasol Clinical Evaluation Study Group. A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology. Transfusion 2010; 50: 2362-2375.
14. Heddle NM, Arnold DM, Webert KE,. Time to rethink clinically important outcomes in platelet transfusion trials. Transfusion 2011; 51: 430-434.
15. Strauss RG,. Clarify the negatives of the MIRASOL noninferiority trial. Transfusion 2011; 51: 1361-1362.
16. AuBuchon JP, Herschel L, Roger J, Taylor H, Whitley P, Li J, Edrich R, Goodrich RP,. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction. Transfusion 2005; 45: 1335-1341.